Washington, DC, October 20, 2004 – Shire Pharmaceuticals Group plc (NASDAQ: SHPGY, LSE: SHP.L, TSE: SHQ CN) announced today that ADDERALL XR® (an extended release, mixed salts amphetamine product) is ...
Philadelphia, US – July 22, 2005 – Shire Pharmaceuticals Group plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that the US Food and Drug Administration (FDA) has approved ADDERALL XR® (mixed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results